Acute Kidney Injury After Cardiac Surgery: Novel Ultrasound Techniques for Prediction of Acute Kidney Injury

NCT ID: NCT03727204

Last Updated: 2021-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-10-15

Study Completion Date

2020-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute Kidney Injury (AKI) is a frequent and important complication to cardiac surgery. This study will evaluate the diagnostic ability of ultrasonographic measures of blood flow in kidneys and liver in predicting AKI after cardiac surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute Kidney Injury (AKI) is a frequent and important complication to cardiac surgery. The pathophysiology is multifactorial, but renal functions in this setting is determined by a complex interplay between renal perfusion, fluid status, cardiac output, mean arterial pressure and back pressure to venous outflow.

Renal perfusion may be quantified with novel ultrasound techniques. Ultrasonography of the kidney and renal vasculature allows for assessment of renal afferent flow and renal venous flow and, together with venous flow patterns of the portal vein and liver veins, may identify patients in risk of AKI.

The study is observational and will describe the diagnostic accuracy of the ultrasound measures in predicting postoperative AKI. Patients will be examined with ultrasound of kidney and liver flow along with echocardiography on on the day before surgery and on the 1st and 4th. In addition, patients are followed with markers of kidney function, fluid balance and invasive measures of mean arterial pressure and central venous pressure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Kidney Injury Acute Renal Failure Cardiac Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aarhus University Hospital

100 patients undergoing on-pump cardiac surgery at Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand

On-pump cardiac surgery

Intervention Type PROCEDURE

All participants will undergo on-pump cardiac surgery

Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand

50 patients undergpoing on-pump cardiac surgery at at Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand

On-pump cardiac surgery

Intervention Type PROCEDURE

All participants will undergo on-pump cardiac surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

On-pump cardiac surgery

All participants will undergo on-pump cardiac surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients ≥ 18 years
* Scheduled for on-pump cardiac surgery
* Oral and written consent

AND

* 1 of the following risk factors for development of postoperative AKI may be included:

* age \> 70 years;
* NYHA (New York Heart Association) 3+4;
* Insulin dependent diabetes;
* Glomerular filtration rate \< 60 ml/min/1,73 m2;
* Ejection fraction \< 35;
* Surgery:

* Combined CABG and valve surgery;
* Any valve surgery except isolated aortic-valve surgery;
* Redo surgery;
* Endocarditis;
* Peripheral vascular disease.

Exclusion Criteria

* Insufficient ultrasonographic imaging of the kidneys;
* Known morphological kidney disease;
* Preoperative dialysis;
* Prior participation in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Aarhus

OTHER

Sponsor Role collaborator

Aarhus University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Johan Fridolf Hermansen

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Juhl-Olsen, MD, PhD

Role: STUDY_CHAIR

Department of Anaesthesiology, Aarhus University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aarhus University Hospital, Department of Anaesthesiology

Aarhus, , Denmark

Site Status

Department of Anesthesiology, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand

Johannesburg, , South Africa

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark South Africa

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1-10-72-267-18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.